Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

8d ago

APRE

PremiumPress Releases

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

1M ago

APRE

PremiumPress Releases

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

2M ago

APRE

PremiumPre-Earnings

APRE Upcoming Earnings Report: What to Expect?

2M ago

APRE

PremiumCompany Announcements

Aprea Therapeutics Secures Funding and Advances Drug Pipeline

2M ago

APRE

PremiumPress Releases

Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers

2M ago

APRE

PremiumPress Releases

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

2M ago

APRE

More APRE News >

APRE News on the Web

2024-05-02

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635

Yahoo Finance

Neutral

2024-04-10

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Yahoo Finance

Neutral

2024-03-26

APRE Stock Earnings: Aprea Therapeutics Misses EPS, Misses Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-26

Buy Rating Affirmed: Aprea Therapeutics Poised for Growth with Strong Pipeline Momentum into 2024

TipRanks News

Bullish

2024-03-26

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Yahoo Finance

Neutral

2024-03-19

Aprea Therapeutics: Strong Buy Rating on Robust Financials and Promising Drug Pipeline

TipRanks News

Bullish

2024-03-15

Aprea Therapeutics CEO acquires $14.6k in company stock

Investing.com

Neutral

2024-03-15

Aprea Therapeutics director buys $50k of company stock

Investing.com

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APRE’s Media Buzz Sentiment?

Currently, no data Available

What is APRE’s weekly average amount of articles?

Currently, no data Available

What is APRE’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

CLDXCelldex

GOSSGossamer Bio

RCKTRocket Pharmaceuticals

IMCRImmunocore Holdings

DHDefinitive Healthcare Corp

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing